Skip to main content
. 2019 Aug 4;2019:7104071. doi: 10.1155/2019/7104071

Table 2.

Demographic data of 32 PD patients.

Included (n=16) Excluded (n=16)
Age, years, median (IQR) 61.5 (9.5) 65.5 (11.5)
Sex, females, n (%) 5 (31) 11 (68)
Duration of disease, years, median (IQR) 13.0 (8.0) 13.5 (4.3)
Duration of medication, years, median (IQR) 11.5 (7.0) 11.0 (4.5)
Hoehn and Yahr stage, median (IQR) 3.0 (1.0) 3.0 (0.3)
Final stimulation setting, median (IQR)
 Pulse, microseconds 60.0 (0.00) 60.0 (7.5)
 Hz 130.0 (0.0) 130.0 (15.0)
 Volts 1.68 (1.21) 2.00 (0.95)
First LEDD 1216 (614) 1281 (473)
Final LEDD 555 (315) 713 (334)
Dominant affected side, right (%) 12 (75) 9 (56)

IQR, interquartile range; LEDD, levodopa equivalent daily dose.